Bio-innova Co., Ltd
🇹🇭Thailand
Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- Drug: Sildenafill-Test productDrug: Sildenafill-Reference product
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT06289881
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT06248801
Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- Drug: Nebivolol-Test productDrug: Nebivolol-Reference product
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 46
- Registration Number
- NCT06248099
Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT06248112
Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®
Phase 1
Recruiting
- Conditions
- Healthy Subjects
- Interventions
- Drug: Drospirenone+ Ethinyl Estradiol Tablets-Test productDrug: Drospirenone+ Ethinyl Estradiol Tablets-Reference product
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT06233071
- Locations
- 🇹🇭
Bio-innova, Bangkok, Thailand
Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- Drug: Ticagrelor-Test productDrug: Ticagrelor-Reference product
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT06233266
Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- Drug: Drospirenone+ Ethinyl Estradiol Tablets-Test productDrug: Drospirenone+ Ethinyl Estradiol Tablets-Reference product
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT06233058
Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT06233097
Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 34
- Registration Number
- NCT06233240
Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- Drug: Dapagliflozin-Reference productDrug: Dapagliflozin-Test product
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Bio-innova Co., Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT06233045
© Copyright 2025. All Rights Reserved by MedPath